Global Heparin Calcium Market to Surpass US$ 1,700.8 Million by 2030, Says Coherent Market Insights (CMI)

Advertisement

Burlingame, Feb. 15, 2023 (GLOBE NEWSWIRE) — According to Coherent Market Insights, the global heparin calcium market is estimated to be valued at US$ 1,370.9 in 2022 and is expected to exhibit a CAGR of 2.7% during the forecast period (2022-2030).

Key Trends and Analysis of the Global Heparin Calcium Market:

Ongoing research and development on low-molecular weight heparin by key market players

Advertisement

Ongoing research and development by key market players is expected to drive the global heparin calcium market growth over the forecast period. For instance, in August 2021, Assistance Publique, the University hospital trust, in collaboration with Johannes Gutenberg University Mainz, Life Sciences Research Partners (D Collen Research Foundation), Canadian Institutes of Health Research (CIHR), and Boehringer Ingelheim, a pharmaceutical company, started a clinical trial to assess the safety and efficacy of low-molecular-weight heparin in patients with high-risk acute pulmonary embolism. This trial is expected to complete in August 2027.

Request Sample copy of this Report @ https://www.coherentmarketinsights.com/insight/request-sample/5483

Key Market Takeaways:

The global heparin calcium market is expected to exhibit a CAGR of 2.7% during the forecast period due to the increasing awareness campaign by the key market players to raise awareness. For instance, in September 2022, The Pulmonary Hypertension Association, announced that they had joined the National Blood Clot Alliance and other health care organizations. The aim of this alliance is to create awareness about pulmonary embolism.

Among application, deep vein thromosis type is expected to hold dominant position in the market due to increasing launch of awareness campaign by key market players over the forecast period. For instance, in October 2019, The Centers for Disease Control and Prevention (CDC) and the National Blood Clot Alliance have launched a “Stop the Clot” campaign to increase the public awareness about the risk factors of deep vein thrombosis

Competitive Landscape:

Key players operating in the global heparin calcium market include Sanofi, Pfizer Inc., Dongying Tiandong Pharmaceutical Co., Ltd., PANPHARMA S.A., Merck KGaA, Teva Pharmaceutical Industries Ltd., SMITHFIELD BIOSCIENCE, Afine Chemicals Limited, Yino Pharma Limited, Shandong Sheelian Pharmaceutical Co., Ltd., Aspen Holdings, Opocrin S.p.A.

Buy-Now this Research Report @ https://www.coherentmarketinsights.com/insight/buy-now/5483

Market Segmentation:

  • Global Heparin Calcium Market, By Type:
    • Unfractionated Heparin
    • Low Molecular Weight Heparin
  • Global Heparin Calcium Market, By Route of Administration:
    • Intravenous
    • Subcutaneous
  • Global Heparin Calcium Market, By Application:
    • Kidney Dialysis
    • Atrial Fibrillation
    • Deep Vein Thrombosis
    • Pulmonary Embolism
    • Others (Cardiac Surgery, etc.)
  • Global Heparin Calcium Market, By Distribution Channel:
    • Hospital Pharmacies
    • Retail Pharmacies
    • Online Pharmacies
  • Global Heparin Calcium Market, By Region:
    • North America
      • By Country
        • U.S.
        • Canada
    • Latin America
      • By Country
        • Brazil
        • Mexico
        • Argentina
        • Rest of Latin America
    • Europe
      • By Country
        • Germany
        • U.K.
        • France
        • Italy
        • Spain
        • Russia
        • Rest of Europe
    • Asia Pacific
      • By Country
        • China
        • India
        • Japan
        • Australia
        • South Korea
        • ASEAN
        • Rest of Asia Pacific
    • Middle East
      • By Country
        • GCC
        • Israel
        • Rest of Middle East
    • Africa
      • By Country/Regions
        • South Africa
        • Central Africa
        • North Africa

Related Market Intelligence Reports:

Anticoagulant Market, By Drug Class (Novel Oral Anticoagulants (NOACs), Heparin and Low-molecular- weight Heparin(LMWH), and Vitamin K Antagonist), By Application (Atrial Fibrillation/Myocardial Infarction (Heart Attack), Deep Vein Thrombosis (DVT), Pulmonary Embolism, and Other Applications), and By Geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America)- Size, Share, Outlook, and Opportunity Analysis, 2022 – 2028

Postmenopausal Osteoporosis Market, by Drug Class (Bisphosphonates, Selective Estrogen Receptor Modulators (SERMs), RANK Ligand Inhibitors, Anabolic Class, Calcium Metabolism Modifiers, and Others (Calcitonin, Denosumab among Others)), by Route of Administration (Oral, Intravenous Route, and Subcutaneous), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)- Size, Share, Outlook, and Opportunity Analysis, 2022 – 2030

About Us:

Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having sales office at global financial capital in the U.S. and sales consultants in United Kingdom and Japan. Our client base includes players from across various business verticals in over 57 countries worldwide. We create value for clients through our highly reliable and accurate reports. We are also committed in playing a leading role in offering insights in various sectors post-COVID-19 and continue to deliver measurable, sustainable results for our clients.

Follow Us: LinkedInTwitter

CONTACT: Mr. Shah Senior Client Partner – Business Development Coherent Market Insights Phone: US: +1-206-701-6702 UK: +44-020-8133-4027 Japan: +81-050-5539-1737 India: +91-848-285-0837 Email: [email protected] Website: https://www.coherentmarketinsights.com

Disclaimer: The above press release comes to you under an arrangement with GlobeNewswire. AfternoonHeadlines.com takes no editorial responsibility for the same.